Elevance (ELV) Q4 Earnings Beat on Premium Growth, Dividend Hiked

Elevance Health, Inc. (ELV) reported fourth-quarter 2023 adjusted earnings of $5.62 per share, which surpassed the Zacks Consensus Estimate by 1.3%. The bottom line climbed 15.2% year over year.Operating revenues rose 7% year over year to almost $42.5 billion in the quarter under review. Also, the top line beat the consensus mark by 1.5%.The strong quarterly results benefited on the back of improved premiums in the Commercial Health Benefits business and better performance in the Carelon Services business. ...